Histological and Genetic Diversity in Ovarian Mucinous Carcinomas: A Pilot Study
Tumor heterogeneity remains an ongoing challenge in the field of cancer therapy. Intratumor heterogeneity significantly complicates the diagnosis of cancer and presents challenging clinical problems due to resistance to drug therapy. This study aimed to elucidate the genetic changes histologically (...
Main Authors: | Sultana Razia, Kentaro Nakayama, Hitomi Yamashita, Tomoka Ishibashi, Masako Ishikawa, Kosuke Kanno, Seiya Sato, Satoru Kyo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/30/4/307 |
Similar Items
-
Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
by: Puja Dey, et al.
Published: (2022-03-01) -
Mutation Profiles of Ovarian Seromucinous Borderline Tumors in Japanese Patients
by: Hiroki Sasamori, et al.
Published: (2022-05-01) -
Ovarian Endometrioid and Clear Cell Carcinomas with Low Prevalence of Microsatellite Instability: A Unique Subset of Ovarian Carcinomas Could Benefit from Combination Therapy with Immune Checkpoint Inhibitors and Other Anticancer Agents
by: Yuki Nonomura, et al.
Published: (2022-04-01) -
A Novel Case of Recurrent Mucinous Borderline Ovarian Tumor: Early Relapse and Fatal Outcome
by: Kyoko Nakagawa, et al.
Published: (2022-05-01) -
Clinical Landscape of PARP Inhibitors in Ovarian Cancer: Molecular Mechanisms and Clues to Overcome Resistance
by: Satoru Kyo, et al.
Published: (2022-05-01)